Korean J Pain.  2015 Apr;28(2):158-159. 10.3344/kjp.2015.28.2.158.

An Update on the Management of Diabetic Neuropathic Pain: A Few Comments

• Ghobadifar MA

• KMID: 2278284
• DOI: http://doi.org/10.3344/kjp.2015.28.2.158

Abstract

No abstract available.

MeSH Terms

Neuralgia*

Reference

1. Nam JS, Cheong YS, Karm MH, Ahn HS, Sim JH, Kim JS, et al. Effects of nefopam on streptozotocin-induced diabetic neuropathic pain in rats. Korean J Pain. 2014; 27:326–333. PMID: 25317281.

2. Mert T, Gunes Y, Ozcengiz D. Modification of local anesthetic-induced antinociception by fentanyl in rats. Pharmacol Rep. 2011; 63:1427–1434. PMID: 22358090.

3. Guntz E, Dumont H, Roussel C, Gall D, Dufrasne F, Cuvelier L, et al. Effects of remifentanil on N-methyl-D-aspartate receptor: an electrophysiologic study in rat spinal cord. Anesthesiology. 2005; 102:1235–1241. PMID: 15915038.

4. Kim HS, Cho JE, Hwang KC, Shim YH, Lee JH, Kwak YL. Diabetes mellitus mitigates cardioprotective effects of remifentanil preconditioning in ischemia-reperfused rat heart in association with anti-apoptotic pathways of survival. Eur J Pharmacol. 2010; 628:132–139. PMID: 19944681.

5. Mert T, Oksuz H, Tugtag B, Kilinc M, Senoglu N, Bilgin R. Modulating actions of NMDA receptors on pronociceptive effects of locally injected remifentanil in diabetic rats. Pharmacol Rep. 2014; 66:1065–1072. PMID: 25443736.